Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

PRECISION OPTICS CORPORATION, INC. POCI

· Healthcare · Electromedical & Electrotherapeutic Apparatus

FY2026 10-K, filed 2026-09-28
SEC EDGAR

Filing evidence summary

Mixed evidenceCoverage 5/5 core metrics

Latest reported free cash flow was -$2M.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Free cash flow was negative

    Latest reported free cash flow was -$2M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2026-06-30.

  • 3 filing risk checks flagged

    Flagged areas: Solvency & liquidity, Dilution.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

  • Revenue expanded

    Latest reported annual revenue changed +65.2% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2026-06-30.

  • Operating margin improved

    Operating margin changed +18.0 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2026-06-30.

Core trend metrics

Latest annual revenue growth
+65.2%
as of 2026-06-30
Latest annual operating margin
-11.1%
as of 2026-06-30
Free cash flow
-$2M
as of 2026-06-30
Debt / equity
0.07x
as of 2026-06-30
ROIC snapshot
-13.2%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

3of 12 rule-based checks flagged
  • Solvency & liquidity
  • Dilution

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-10-21
Latest period end
2026-06-30
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2026-06-3010-K filed 2026-09-28prior period 2025-06-30 from the same filingView filing
By product or service
Revenue
  • Systems Manufacturing$22.6M
    71.8%
    +172.9% yoy
  • Ross Optical Industries$4.91M
    15.6%
    +31.7% yoy
  • Engineering Design Services$3.47M
    11.0%
    -29.7% yoy
  • Micro Optics Lab$520K
    1.6%
    -75.7% yoy

Members sum to the consolidated $31.5M for this period.

Latest quarter
Quarter ending 2026-03-3110-Q filed 2026-05-13prior period 2025-12-31 from the same filingView filing
  • Systems Manufacturing$6.19M
    71.1%
    no prior
  • Ross Optical Industries$1.32M
    15.2%
    no prior
  • Engineering Design Services$1.06M
    12.2%
    no prior
  • Micro Optics Lab$138K
    1.6%
    no prior

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2026-06-30 · among 4,060 US-listed filers · 314 in Healthcare
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$32M
18thof 3,247
bottom third
21stof 285
bottom third
Revenue growth
latest fiscal-year revenue vs the prior fiscal year
65.2%
92ndof 3,083
top third
95thof 270
top third
Gross margin
gross profit ÷ revenue
17.2%
17thof 1,585
bottom third
4thof 206
bottom third
Operating margin
operating income ÷ revenue
-11.1%
31stof 2,777
bottom third
43rdof 274
middle third
Net margin
net income ÷ revenue
-11.5%
29thof 3,212
bottom third
42ndof 284
middle third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
-6.3%
26thof 2,640
bottom third
37thof 256
middle third
Return on equity
net income ÷ stockholders' equity (positive equity only)
-17.8%
29thof 3,520
bottom third
43rdof 286
middle third
Stock comp ÷ revenue
stock-based compensation ÷ revenue · lower is ranked higher
3.6%
41stof 2,852
middle third
49thof 270
middle third
Days sales outstanding
receivables ÷ revenue × 365 · lower is ranked higher
69 days
28thof 2,373
bottom third
29thof 259
bottom third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-8.0%
66thof 3,845
middle third
54thof 299
middle third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
-4.7%
68thof 3,301
top third
67thof 261
top third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2026-06-30 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-8.0%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
-4.7%
change in net operating assets ÷ average net operating assets
Cash-backed years
4 of 5
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
-
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 10 changed periods
Line itemPeriodFirst reportedLatest filingChangeFilings
Operating income
OperatingIncomeLoss
quarter 2022-09-30-$16.6K
10-Q 2022-11-14
-$102K
10-Q 2023-11-14
-513.7%first · latest · 3 filings carry it
Net income
NetIncomeLoss
quarter 2022-09-30-$73.5K
10-Q 2022-11-14
-$159K
10-Q 2024-05-15
-115.9%first · latest · 6 filings carry it
Net income
NetIncomeLoss
quarter 2022-12-31$634K
10-Q 2023-02-14
$509K
10-Q 2024-05-15
-19.8%first · latest · 4 filings carry it
Operating income
OperatingIncomeLoss
quarter 2022-12-31$697K
10-Q 2023-02-14
$571K
10-Q 2024-02-14
-18.1%first · latest · 3 filings carry it
Stock-based compensation
ShareBasedCompensation
fiscal year 2025-06-30$1.46M
10-K 2025-09-29
$1.61M
10-K 2026-09-28
+10.4%first · latest
Gross profit
GrossProfit
quarter 2022-09-30$1.72M
10-Q 2022-11-14
$1.64M
10-Q 2023-11-14
-4.9%first · latest · 3 filings carry it
Gross profit
GrossProfit
quarter 2022-12-31$2.73M
10-Q 2023-02-14
$2.6M
10-Q 2024-02-14
-4.6%first · latest · 3 filings carry it
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
fiscal year 2025-06-30-$3.55M
10-K 2025-09-29
-$3.4M
10-K 2026-09-28
+4.3%first · latest
Stockholders' equity
StockholdersEquity
balance at 2022-12-31$9.85M
10-Q 2023-02-14
$9.64M
10-Q 2024-05-15
-2.1%first · latest · 4 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2022-09-30$8.97M
10-Q 2022-11-14
$8.89M
10-Q 2024-05-15
-0.9%first · latest · 6 filings carry it

6 share-count periods re-presented for a stock split (1-for-3) are listed apart from restatements and not counted above.

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding; share counts re-presented by an integer split ratio are listed as split adjustments, not restatements. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

debt, leases, revenue, segments, contingencies, taxes and more · the filer's own words
Latest annual report10-K FY2026 · filed 20260928View filing
Employee benefit plans · 278 characters as filed

(5) PROFIT SHARING PLAN The Company has a defined contribution 401(k) profit sharing plan. Employer profit sharing and matching contributions to the plan are discretionary. No employer profit sharing or matching contributions were made to the plan in fiscal years 2026 and 2025.

CompensationAndEmployeeBenefitPlansTextBlock

Revenue disaggregation · 283 characters as filed

Schedule of disaggregation of revenues Year Ended June 30, 2026 2025 Engineering Design Services $ 3,473,640 $ 4,938,158 Systems Manufacturing 22,628,047 8,290,225 Micro Optics Lab 519,540 2,135,562 Ross Optical Industries 4,910,538 3,727,324 Total Revenues $ 31,531,765 $ 19,091,269

DisaggregationOfRevenueTableTextBlock

Income taxes · 2,886 characters as filed

(4) INCOME TAXES The Company has identified its federal tax return and its state tax return in Massachusetts as major tax jurisdictions. The periods subject to examination for its federal and state income tax returns are the years ended in 2018 and thereafter. The Company believes its income tax filing positions and deductions will be sustained on audit and it does not anticipate any adjustments that would result in a material change to its financial position. Therefore, no liabilities for uncertain income tax positions have been recorded. The provision for income taxes in the accompanying consolidated statements of operations consists of the state income tax liability of $ 4,958 and $ 1,936 for the years ended June 30, 2026, and 2025. A reconciliation of the federal statutory rate to the Companys effective tax rate for the fiscal years ended June 30, 2026 and 2025 is as follows: Schedule of effective income tax rate reconciliation Year Ended June 30, 2026 Income tax expense (benefit) at federal statutory rate $ (762,277 ) (21.0 )% Increase (decrease) in tax resulting from: State taxes, net of federal benefit (1) (229,409 ) (6.3 )% Change in valuation allowance (2) 702,542 19.3 % Stock based compensation 311,364 8.6 % Nondeductible items (17,262 ) (0.5 )% Effective tax rate $ 4,958 $ 0.1% Year Ended June 30, 2025 Income tax expense (benefit) at federal statutory rate $ (1,213,852 ) (21.0 )% Increase (decrease) in tax resulting from: State taxes, net of federal benefit (1) (36 …

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

New accounting pronouncements · 1,787 characters as filed

(p) Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which enhances income tax disclosure requirements, primarily related to the rate reconciliation and income taxes paid. The Company adopted ASU 2023-09 effective July 1, 2025. The adoption of ASU 2023-09 resulted in additional disclosures within the Companys consolidated financial statements and did not have a material impact on the Companys financial statements. In November 2024, the FASB issued ASU 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03), which requires additional disclosures about certain expenses included in the expense captions presented on the statement of operations. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance on its financial statement disclosures. In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities (ASU 2025-10). ASU 2025-10 adds guidance on the recognition, measurement and presentation of government grants. ASU 2025-10 is effective for fiscal years beg …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

Significant accounting policies · 21,012 characters as filed

(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (a) Nature of Business Precision Optics Corporation, Inc. (the Company) designs, develops, manufactures and sells specialized optical and illumination systems and related components. The Company conducts business in one industry segment only and its customers are primarily domestic. The Company performs advanced optical and illumination system design, development, assembly and manufacturing services, and sources for resale specialized optical components for products that fall into two principal areas: (i) medical products for use by hospitals and physicians; and (ii) products used by defense contractors, aerospace and industrial customers. (b) Revenues The Company determines revenue recognition for arrangements that we determine are within the scope of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers , (ASC 606), by performing the following five steps: (i) identify the contract with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when, or as, we satisfy the performance obligations. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within the contract and determine those that are performance obligations and assess whether each promised good or servi …

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

Stockholders' equity · 7,712 characters as filed

(3) STOCKHOLDERS EQUITY (a) Stock-Based Compensation Expense The following table summarizes stock-based compensation expense for the years ended June 30: Schedule of stock-based compensation expense 2026 2025 Cost of Goods Sold $ 135,079 $ 154,559 Selling, General and Administrative Expenses 1,004,613 1,457,547 Stock Based Compensation Expense $ 1,139,692 $ 1,612,106 As of June 30, 2026, the unrecognized compensation costs related to options vesting in the future was $ 853,104 . No compensation has been capitalized because such amounts would have been immaterial. There was no net income tax benefit recognized related to such compensation for the years ended June 30, 2026, or 2025, as the Company is currently in a loss position. There were 233,353 stock options granted during the year ended June 30, 2026, and 520,000 stock options granted during the year ended June 30, 2025. The Company uses the Black-Scholes option-pricing model as the most appropriate method for determining the estimated fair value for the stock awards. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock award; (2) the expected future stock volatility over the expected term; and (3) risk-free interest rate. The expected term represents the expected period of time the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Companys common …

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.